Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database

Background: It is thought that older patients with multiple sclerosis (MS) may present with a different clinical disease phenotype, and therefore respond to subcutaneous interferon beta-1a (sc IFN β-1a) differently to younger patients. However, few real-world data are available concerning the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Allignol, Arthur, Boutmy, Emmanuelle, Sabidó Espin, Meritxell, Marhardt, Kurt, Vermersch, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351462/
https://www.ncbi.nlm.nih.gov/pubmed/34381411
http://dx.doi.org/10.3389/fneur.2021.676585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351462/
https://www.ncbi.nlm.nih.gov/pubmed/34381411
http://dx.doi.org/10.3389/fneur.2021.676585

Ejemplares similares